tirzepatide safety vs semaglutide safety vs. Tirzepatide: Understanding Which is Best for You Tirzepatide vs. Semaglutide for Weight

The AI body scan calculates an individual's Basal Metabolic Rate (BMR) with greater precision by incorporating lean body mass, fat mass, and other metrics

10.5493/wjem.v14.i2.93689

Your body starts burning through its fat stores

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (Mounjaro) and chronic weight management (Zepbound) in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity, as an adjunct to diet and physical activity

Across four major trials, tirzepatide consistently delivered outcomes that exceed every previously available treatment